Stocksigma LogoStocksigma Logo

Ind-Swift Laboratories Reports Preferential Warrant Proceeds Utilization for Q2FY27

CARE Ratings issued its Monitoring Agency Report for Ind-Swift Laboratories regarding its Rs 137.20 crore preferential warrant issue allotted on 17th

Ind-Swift Laboratories Reports Preferential Warrant Proceeds Utilization for Q2FY27

Ind-Swift Laboratories Ltd 路 Others (Uncategorized) 路 03 Nov 2026, 8:26 pm

Ind-Swift Laboratories Reports Preferential Warrant Proceeds Utilization for Q2FY27 CARE Ratings issued its Monitoring Agency Report for Ind-Swift Laboratories regarding its Rs 137.20 crore preferential warrant issue allotted on 17th Sep'26. As of 30th Sep'26, the company raised Rs 34.30 crore, utilizing Rs 15.60 crore and leaving Rs 18.70 crore unutilized in ICICI Bank fixed deposits. Deployments included Rs 6.315 crore for facility expansion, Rs 4.853 crore in Dubai subsidiary ISLL Middle East, Rs 3.989 crore for working capital, Rs 0.335 crore for R&D, and Rs 0.108 crore for GCP. CARE noted zero material deviations.

Original exchange filing (PDF)

More announcements from Ind-Swift Laboratories Ltd

All Ind-Swift Laboratories Ltd announcements